GRDN vs OMCL
GRDN: Guardian is a specialized pharmacy services provider delivering high-touch clinical and dispensing solutions to long-term care facilities, particularly assisted living and behavioral health settings, to improve medication adherence and reduce healthcare costs. OMCL: Omnicell automates medication management across healthcare settings through storage, dispensing, and intelligence solutions to enable safer, more efficient pharmacy operations.
Side-by-side fundamentals
| Metric | GRDN | OMCL | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $39.77 | $40.86 | |
| Market cap as of 2026-07-23 | $2.6B | $1.9B | |
| P/E as of 2026-07-23 | 48.45 | 91.01 | GRDN lower |
| PEG as of 2026-07-23 | n/a | 2.94 | |
| Net margin as of 2026-07-23 | +3.6% | +1.7% | GRDN higher |
| Gross margin as of 2026-07-23 | +20.9% | +43.5% | OMCL higher |
| Operating margin as of 2026-07-23 | +5.3% | +2.8% | GRDN higher |
| ROE as of 2026-07-23 | +27.2% | +1.6% | GRDN higher |
| ROA as of 2026-07-23 | +13.4% | +1.0% | GRDN higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.13 | GRDN lower |
| Revenue growth (YoY) as of 2026-07-23 | +11.3% | +7.9% | GRDN higher |
| Revenue CAGR (3y) SEC XBRL | n/a | -2.9% | |
| Beta as of 2026-07-23 | 0.35 | 0.97 | |
| 1-year return as of 2026-07-22 close | +95.8% | +44.6% | GRDN higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.